Search Within

Graduate Medical Education

Formats
  1. Meeting Abstract (1835)
  2. Journal Article (1732)
  3. Review (351)
  4. Editorial (163)
  5. Research Letter (86)
  6. Correspondence (61)
  7. Book Section (46)
  8. Miscellaneous (42)
  9. Conference Paper (19)
  10. Guidelines (7)
Groups
  1. Department of Medicine (2125)
  2. Sloan Kettering Institute Postdocs (1696)
  3. GME, Medicine (1642)
  4. Surgery (1422)
  5. Solid Tumor Oncology Division (1321)
  6. Survivorship Research (1184)

More Groups

People
  1. Nadeem Abu-Rustum (215)
  2. Britta Weigelt (176)
  3. Michael Scordo (174)
  4. Gunjan Shah (166)
  5. Kylee Maclachlan (155)
  6. Sergio Giralt (150)

More People

Years
  1. 2025 (399)
  2. 2024 (951)
  3. 2023 (912)
  4. 2022 (957)
  5. 2021 (486)
  6. 2020 (257)

More Years

Publications
  1. Journal of Clinical Oncology (375)
  2. Blood (355)
  3. International Journal of Radiation Oncology, Biology, Physics (203)
  4. Annals of Surgical Oncology (183)
  5. Gynecologic Oncology (165)
  6. Laboratory Investigation (105)

More Publications

Publishers
  1. Elsevier Inc. (813)
  2. American Society of Clinical Oncology (443)
  3. American Society of Hematology (402)
  4. Springer (323)
  5. Nature Publishing Group (269)
  6. Lippincott Williams & Wilkins (219)

More Publishers

Results (4342)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacological management of progressive-fibrosing interstitial lung diseases
    Book Section

    Lazo, K.; Ibrahem, M.
    In Esquinas, A. M. (Eds.) Respiratory Ventilatory Strategies in Acute and Chronic Respiratory Failure in Idiopathic Pulmonary Diseases: A Practical Approach (2020)

    Fulltext@MSK | Save
  • Circulating tumor cells (CTC) in cerebrospinal fluid (CSF) as a predictor of survival in CNS metastases
    Meeting Abstract

    Diaz, M.; Singh, P.; Kotchekov, I.; Skakodub, A.; Reiner, A.; Panageas, K.; Ramanathan, L.; Pentsova, E.
    Neuro-Oncology Advances (2020)

    Fulltext@MSK | Save
  • Duration of post-autologous hematopoietic cell transplant anemia and thrombocytopenia are associated with prolonged hospital length-of-stay for multiple myeloma patients
    Meeting Abstract

    Zheng-Lin, B.; Krishnamurthi, N.; Diamond, B.; Maclachlan, K. H.; Maura, F.; Landgren, O.; Chung, D. J.
    Blood (2020)

    Fulltext@MSK | Save
  • Venetoclax re-treatment of chronic lymphocytic leukemia (CLL) patients after a previous venetoclax-based regimen
    Meeting Abstract

    Thompson, M. C.; Allan, J. N.; Sail, K.; Manzoor, B. S.; Pu, J. J.; Barr, P. M.; Coombs, C. C.; Schuster, S. J.; Skarbnik, A.; Rhodes, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase 1 and dose expansion study of APR-246 in combination with ibrutinib or venetoclax-based therapy in subjects with TP53-mutant relapsed and/or refractory non-hodgkin lymphomas (NHL) including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)
    Meeting Abstract

    Thompson, M. C.; Davids, M. S.; Jain, N.; Soumerai, J. D.; Geethakumari, P. R.; Gubits, A.; Hickman, D.; Wennborg, A.; Attar, E. C.; Abdel-Wahab, O.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Worldwide examination of patients with CLL hospitalized for COVID-19
    Meeting Abstract

    Roeker, L. E.; Scarfo, L.; Chatzikonstantinou, T.; Abrisqueta, P.; Eyre, T. A.; Cordoba, R.; Prat, A. M.; Villacampa, G.; Leslie, L. A.; Koropsak, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Whole-genome sequencing reveals evidence of two biologically and clinically distinct entities: Progressive versus stable myeloma precursor disease
    Meeting Abstract

    Oben, B.; Froyen, G.; Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Abascal, F.; Leongamornlert, D. A.; Derkach, A.; Geerdens, E.; Diamond, B.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Prediction of COVID-19 mortality in patients with cancer
    Meeting Abstract

    Mantha, S.; Jee, J.; Soff, G. A.; Pessin, M. S.
    Blood (2020)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and poor clinical outcome in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • The genomic complexity of multiple myeloma precursor disease can be predicted using copy number signatures on targeted sequencing and SNP array data
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; Landgren, O.; more...
    Blood (2020)

    Fulltext@MSK | Save